ITMCTR2100004833招募中4 期
Post-marketing hospital centralized monitoring of clinical safety of Shuganning injection
The First Affiliated Hospital of Henan University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational study
入排标准
- 性别
- All
入选标准
- •1.During the monitoring period, all inpatients receiving Shuganning injection were observed;
- •2.The same patient with different times of medication, the interval between two times of medication is less than 3 days (<= 3 days), which is regarded as one observation object. More than 3 days (> 3 days), according to the new observation object.
排除标准
- •Inpatients who are unable to collect the information needed for this study.
研究者
相似试验
尚未招募
4 期
Hospital Centralized Monitoring of Post-market Clinical Safety of Guipi MixtureSleep DisordersG47.900ITMCTR2024000037Anning First People's Hospital
已完成
不适用
A Multicenteric study to estimate the burden of rotavirus gastroenteritis among hospitalization due to diarrhea.CTRI/2012/03/002475Shantha Biotechnics Limited2,000
已完成
不适用
Hospital-based, Prospective, MulticentreSurveillance to determine the incidence ofintussusception in children aged < 15 Years inGermanyK56.1K38.8Other specified diseases of appendixIntussusceptionDRKS00000359Ruhr-Universität BochumAbteilung für Medizinische Informatik, Biometrie und Epidemiologie1,593
尚未招募
不适用
Continuous monitoring of patients in and after the acute admission ward to optimize clinical pathwayspatiënten die voor verschillende redenen op de acute opname afdeling komenpatients in the Acute Admission WardNL-OMON51219Rijnstate Ziekenhuis800
尚未招募
4 期
Hospital centralized monitoring of clinical safety of Shenkang Injection after marketing/AITMCTR2100005034The First Affiliated Hospital of He'nan University of Chinese Medicine